Biomaterial Database

[Dopamine 17-beta-hydroxylase in chronic uremic patients under periodic hemodialytic treatment]. 1979

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

UI	MeSH Term	Description	Entries
D012083	Renin	A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19.	Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002908	Chronic Disease	Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).	Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004299	Dopamine beta-Hydroxylase		Dopamine beta-Monooxygenase,Dopamine beta Hydroxylase,Dopamine beta Monooxygenase,beta-Hydroxylase, Dopamine,beta-Monooxygenase, Dopamine
D006435	Renal Dialysis	Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.	Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804	Angiotensin II	An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.	Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D014511	Uremia	A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.	Uremias

Related Publications

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

[Changes in prolactin in uremic patients under periodic hemodialytic treatment].

January 1982, Minerva nefrologica,

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

[Gynecomastia in the uremic patient undergoing periodic hemodialytic treatment].

January 1969, Minerva nefrologica,

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

[Study of plasma renin activity in uremic patients undergoing periodic hemodialytic treatment].

April 1974, Chirurgia e patologia sperimentale,

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

[Occurrence of extensive intrarenal cystic lesions in a uremic population under periodic hemodialytic treatment].

January 1985, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

Left ventricular diastolic dysfunction in patients under periodic hemodialytic treatment.

September 1999, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

[Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment].

July 1980, La Clinica terapeutica,

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

[Social and occupational rehabilitation of patients under periodic hemodialytic treatment].

January 1971, Minerva nefrologica,

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

[Behavior of CK-MB in uremic patients undergoing periodic hemodialytic treatment. Considerations and proposals].

December 1985, La Clinica terapeutica,

M Cagossi, and G M Pigliucci, and M R Ruvolo, and G Porcelli

[Endocrine profiles in patients with chronic renal insufficiency under periodic hemodialytic treatment and after renal transplantation].

April 1981, Giornale di clinica medica,